/People

Yakun Wan

Founder

Founder & CEO at Novamab

Shanghai, China

FoundedNovamab

Find your path to Yakun

165 people in our graph can introduce you to Yakun.

Sign up to see every warm intro you have to Yakun

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Yakun. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Yakun Wan is the founder and CEO of Shanghai Novamab Biopharmaceuticals, where the focus is on nanobody-based drug development. Wan has worked in nanobody drug research and development for over 17 years and has led the development of inhaled nanobody drugs LQ036 and LQ043H, which target IL-4R and TSLP for moderate to severe asthma and have each completed Phase I clinical studies. Novamab is also developing nanobody-based treatments for idiopathic pulmonary fibrosis, cystic fibrosis, and other immunological diseases.

Founder & CEO at Novamab

Intro paths

→

In turn, Yakun can intro founders to Novamab's investors below.

Novamab's investors · 1

Experience

  1. Novamab pharmaceuticalsCEO and foundercurrent2017 — presentShanghai, China
  2. Chinese Academy of SciencesGroup leader2015 — 2017Shanghai, China
  3. Southeast UniversityGroup Leader2011 — 2015Nanjing, Jiangsu, China

Skills & more

生命科学1分子生物学1技术转让1肿瘤免疫治疗抗体药物1药品研发1

From Yakun's professional profile.

Frequently asked questions

Who is Yakun Wan?
Yakun Wan is the founder and CEO of Shanghai Novamab Biopharmaceuticals, where the focus is on nanobody-based drug development. Wan has worked in nanobody drug research and development for over 17 years and has led the development of inhaled nanobody drugs LQ036 and LQ043H, which target IL-4R and TSLP for moderate to severe asthma and have each completed Phase I clinical studies. Novamab is also developing nanobody-based treatments for idiopathic pulmonary fibrosis, cystic fibrosis, and other immunological diseases.
Where does Yakun Wan work?
Yakun Wan is Founder & CEO of Novamab.
What companies did Yakun Wan found?
Yakun Wan founded Novamab.
Where did Yakun Wan go to school?
Yakun Wan studied at Institute for Systems Biology (Researcher, Systems Biology); Baylor College of Medicine (Postdoctoral fellow, Human/Medical Genetics); The University of Texas at Austin (Postdoctoral fellow, Molecular Genetics).

Founder mafias

Institute for Systems Biology mafia2

Also came through, then founded or led a company.

Same school

Shared employers